Recursion Pharmaceuticals, Inc. RXRX Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s income tax?
- Recursion Pharmaceuticals, Inc. (RXRX) reported income tax of -$4.6M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s income tax changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s income tax decreased by 2813.9% year-over-year, from -$158K to -$4.6M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.